Conduit Pharmaceuticals Files 2024 10-K
Ticker: CDTTW · Form: 10-K · Filed: Mar 28, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 10-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, annual-report
TL;DR
Conduit Pharma (formerly Murphy Canyon) filed its 2024 10-K. All eyes on their next move.
AI Summary
Conduit Pharmaceuticals Inc. filed its 2024 10-K on March 28, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021, is in the pharmaceutical preparations industry. Its principal executive offices are located in Naples, Florida.
Why It Matters
This filing provides investors with a comprehensive overview of Conduit Pharmaceuticals' financial performance and business operations for the fiscal year 2024, including key financial statements and disclosures.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Conduit Pharmaceuticals is subject to significant regulatory, research and development, and market risks inherent in the industry.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 001-41245 — SEC File Number (Company's SEC filing identifier)
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Filer of the 10-K
- Murphy Canyon Acquisition Corp. (company) — Former name of Conduit Pharmaceuticals Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-28 (date) — Filing date
- Naples, Florida (location) — Business address
FAQ
What is Conduit Pharmaceuticals Inc.'s primary business activity?
Conduit Pharmaceuticals Inc. operates in the Pharmaceutical Preparations industry, as indicated by its SIC code 2834.
When did Conduit Pharmaceuticals Inc. change its name from Murphy Canyon Acquisition Corp.?
The company changed its name from Murphy Canyon Acquisition Corp. on November 30, 2021.
What is the fiscal year end for Conduit Pharmaceuticals Inc.?
The fiscal year end for Conduit Pharmaceuticals Inc. is December 31.
Where is Conduit Pharmaceuticals Inc. located?
Conduit Pharmaceuticals Inc. is located at 4851 Tamiami Trail North, Suite 200, Naples, Florida 34103.
What is the SEC file number for Conduit Pharmaceuticals Inc.?
The SEC file number for Conduit Pharmaceuticals Inc. is 001-41245.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 28, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).